CXCL8 and arthritic joint disease: Thiamet-G, another O-GlcNAcase inhibitor, has been shown to increase O-GlcNAc-modified proteins and reduce the production of pro-inflammatory cytokines (IL-6 and IL-8) in arthritis [39].